You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Medtronic knows how committed you are to helping patients manage their health. We share your commitment with a passion for providing lifelong solutions that can assist you in managing patients' chronic medical conditions. Our products range from diagnostic equipment to therapies that manage long-term conditions where other medical therapies have failed.
In continuing to this website, you acknowledge you are a registered healthcare professional and I have a valid certification in your possession.
By clicking 'Accept' below you agree that you are a registered healthcare professional and you have a valid certification in your possession.
Refer to technical manual and Instruction for Use (IFU) for complete list of indications, contraindications, warnings and precautions.
COMMUNICATION IS CRITICAL
Evidence suggests that breakdowns in the bowel-brain communication pathway are the root cause of chronic fecal incontinence (FI)1,2 While other therapies focus on the bowel muscles, Medtronic therapies target the nerves, which is thought to help restore normal bowel function.2
When more conservative treatments fail, Medtronic Bowel Control Therapy delivered by the InterStim™ system can help. This therapy is so simple and discreet patients might forget they have it. And it delivers the kind of relief that allows enjoyment of favourite activities without a second thought.
Implanting an InterStim system has risks similar to any surgical procedure, including swelling, bruising, bleeding, and infection. Talk with your doctor about ways to minimise these risks.
Medtronic Bowel Control Therapy delivered by the InterStim system provides life-changing relief.
The most frequently occurring device/therapy-related adverse events were implant site pain, paresthesia, change in sensation of stimulation, implant site infection, urinary incontinence, neurostimulator battery depletion, diarrhea, pain in extremity, undesirable change in stimulation, and buttock pain.
Restored bowel function is defined as 50% or more reduction in chronic fecal incontinence episodes.
Success defined as ≥ 50% reduction of episodes/week. This patient group had data at both baseline and the 5 year visit. Another analysis reported 69% of people achieved success with Medtronic Bowel Control Therapy. For this patient group, missing data at 5 years because of a device-related reason was counted as failure or if it was missing for non-device related reasons, the most recent data was carried forward.
Tjandra JJ, Chan MKY, Yeh CH, Murray-Green C. Sacral nerve stimulation is more effective than optimal medical therapy for severe fecal incontinence: a randomized, controlled study. Dis Colon Rectum. 2008;51(5):494–502.
Gourcerol G, Vitton V, Leroi AM, et al. How sacral nerve stimulation works in patients with faecal incontinence. Colorectal Dis. 2011;13(8):e203–211.
This information is designed to provide you with helpful educational information but is for information purposes only, is not medical advice, and should not be used as an alternative to speaking with your doctor. No representation is made that the information provided is current, complete, or accurate. Medtronic does not assume any responsibility for persons relying on the information provided. Be sure to discuss questions specific to your health and treatments with a healthcare professional. For more information please speak to your healthcare professional.